Evidence record 7699 · automatically gathered

Predicting Response to Neoadjuvant Chemotherapy with PET Imaging Using Convolutional Neural Networks

Imaging of cancer with 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) has become a standard component of diagnosis and staging in oncology, and is becoming more important as a quantitative monitor of individual response to therapy. In this article we investigate the challenging problem of predicting a patient's response to neoadjuvant chemotherapy from a single 18F-FDG PET scan taken prior to treatment. We take a "radiomics" approach whereby a large amount of quantitative feat

Record details

Published: 10 September 2015
Source: OpenAlex
Category: Research
Topics: Healthcare · Finance, VC & PE
Retrieved: 14 July 2026

source-onlyevidence status

These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.

How to cite this record

ethics.ai (10 September 2015), “Predicting Response to Neoadjuvant Chemotherapy with PET Imaging Using Convolutional Neural Networks,” evidence record 7699, https://ethics.ai/record/7699 (originally published by OpenAlex).

JSON

Use and limitations

This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.